EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY-NC 3.0

Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study

Jessica A Breznik iD, Ahmad Rahim, Hina Bhakta, Rumi Clare, Ali Zhang, Jann Ang, Hannah D Stacey, Li-Min Liu, Allison Kennedy, Lucas Bilaver, Megan Hagerman, Tara Kajaks und 6 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.29170 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Jessica A Breznik und 17 weiteren Autor:innen. Beteiligte Einrichtung: McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Long-Term Care, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenicity of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) bivalent mRNA‐1273.214 vaccine (Original/Omicron B.1.1.529 [BA.1]) is underreported in vulnerable older adults in congregate care settings. In residents of 26 long‐term care and retirement homes in Ontario, Canada, humoral (i.e., serum anti‐spike and anti‐receptor binding domain [anti‐RBD]) IgG and IgA antibodies and live SARS‐CoV‐2 neutralization) and cellular (i.e., CD4 + and CD8 + activation‐induced marker spike‐specific T cell memory) responses were assessed 7–120 days postvaccination with four monovalent mRNA vaccines ( n = 494) or subsequent bivalent mRNA‐1273.214 vaccination (fifth vaccine) ( n = 557). Within 4 months, anti‐spike and anti‐RBD antibody levels were similar after monovalent and bivalent vaccination in infection‐naïve individuals. Hybrid immunity (i.e., vaccination and natural infection) generally increased humoral responses. After bivalent vaccination, compared to monovalent vaccination, residents with hybrid immunity had elevated anti‐spike and anti‐RBD IgG and IgA antibodies. Omicron BA.1 antibody‐mediated neutralization, and CD8 + T cell memory responses to the Omicron BA.1 spike protein, were also higher after bivalent vaccination. Humoral and cellular responses were, therefore, noninferior within 4 months of bivalent mRNA‐1273.214 vaccination compared to monovalent mRNA vaccination. Waning of humoral but not cellular immunity was particularly evident in individuals without hybrid immunity. Continued monitoring of vaccine‐associated and hybrid immunity against emerging Omicron variants of concern is necessary to assess longevity of protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Long-Term CareCOVID-19HumansAgedOntarioRetirementSARS-CoV-2mRNA VaccinesVaccinationCohort StudiesImmunoglobulin AImmunoglobulin GAntibodies, ViralAntibodies, NeutralizingCOVID-19 Vaccines

Stichwörter der Autor:innen

COVID-19SARS-CoV-2bivalent mRNA vaccineshumoral immunityolder adultsvaccine immunogenicity

Substanzen

mRNA VaccinesImmunoglobulin AImmunoglobulin GAntibodies, ViralAntibodies, NeutralizingmRNA-1273.214 COVID-19 vaccineCOVID-19 Vaccines

Autor:innen und Institutionen

  • McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Centre for Integrated Care, St. Joseph's Health System, Hamilton, Ontario, Canada.
  • Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.

ORCID-Profile: Jessica A Breznik

Zitieren

APA

Breznik, J. A., Rahim, A., Bhakta, H., Clare, R., Zhang, A., Ang, J., Stacey, H. D., Liu, L. M., Kennedy, A., Bilaver, L., Hagerman, M., Kajaks, T., Bramson, J. L., Nazy, I., Miller, M. S., Costa, A. P., Bowdish, D. M. E., & COVID in LTC Investigator Group (2023). Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study. Journal of Medical Virology. https://doi.org/10.1002/jmv.29170

Vancouver

Breznik JA, Rahim A, Bhakta H, Clare R, Zhang A, Ang J, et al. Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study. Journal of Medical Virology. 2023. doi:10.1002/jmv.29170

BibTeX
@article{Breznik2023,
  author = {Breznik, Jessica A and Rahim, Ahmad and Bhakta, Hina and Clare, Rumi and Zhang, Ali and Ang, Jann and Stacey, Hannah D and Liu, Li-Min and Kennedy, Allison and Bilaver, Lucas and Hagerman, Megan and Kajaks, Tara and Bramson, Jonathan L and Nazy, Ishac and Miller, Matthew S and Costa, Andrew P and Bowdish, Dawn M E and COVID in LTC Investigator Group, COVID in LTC Investigator Group},
  title = {Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.29170}
}
Kostenlos starten →